Page last updated: 2024-08-24

colestipol and Arteriosclerosis, Coronary

colestipol has been researched along with Arteriosclerosis, Coronary in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19903 (18.75)18.7374
1990's11 (68.75)18.2507
2000's2 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azen, SP; LaBree, L; Lapuerta, P1
Azen, SP; Cashin-Hemphill, L; Hodis, HN; Johnson, R; LaBree, L; Mack, WJ; Sevanian, A1
Davies, G; Kitano, Y; Maher, VM; Matthews, S; Mir, A; Neuwirth, C; Prescott, RJ; Rees, A; Shortt, MB; Thompson, GR1
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Hodis, HN; LaBree, L; Mack, WJ; Selzer, RH; Shircore, AM1
Brown, BG; Brunzell, JD; Hokanson, JE; Zambon, A1
Hodis, HN; Mack, WJ; Selzer, RH; Xiang, M1
Hodis, HN; LaBree, L; Liu, C; Mack, WJ; Selzer, RH1
Azen, SP; Blankenhorn, DH; Crawford, DW; Lee, PL; Mack, WJ; Pogoda, J; Selzer, RH; Shircore, AM1
Azen, SP; Blankenhorn, DH; Lee, PL; Mack, WJ; Pogoda, JM; Selzer, RH; Shircore, AM1
Brown, BG1
Diehl, JC; Havel, RJ; Kane, JP; Malloy, MJ; Phillips, NR; Ports, TA1
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Mack, WJ; Pogoda, JM; Sanmarco, ME1
Alaupovic, P; Azen, SP; Blankenhorn, DH; Chin, HP; Wickham, E1
Dereviacki, BE; Forti, N; Giannini, SD1
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Johnson, RL; Nessim, SA; Sanmarco, ME1

Reviews

1 review(s) available for colestipol and Arteriosclerosis, Coronary

ArticleYear
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
    Arquivos brasileiros de cardiologia, 1988, Volume: 51, Issue:1

    Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol

1988

Trials

13 trial(s) available for colestipol and Arteriosclerosis, Coronary

ArticleYear
Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis.
    JAMA, 1995, Jun-21, Volume: 273, Issue:23

    Topics: Adult; Analysis of Variance; Antioxidants; Ascorbic Acid; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Diet, Atherogenic; Food, Fortified; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin E

1995
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
    Lancet (London, England), 1995, Apr-01, Volume: 345, Issue:8953

    Topics: Adult; Blood Component Removal; Cholestyramine Resin; Colestipol; Coronary Angiography; Coronary Artery Disease; Data Interpretation, Statistical; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lovastatin; Middle Aged; Odds Ratio; Simvastatin

1995
Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study.
    Circulation, 1996, Jan-01, Volume: 93, Issue:1

    Topics: Adult; Colestipol; Coronary Angiography; Coronary Artery Disease; Diet, Fat-Restricted; Follow-Up Studies; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Predictive Value of Tests

1996
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
    Circulation, 1999, Apr-20, Volume: 99, Issue:15

    Topics: Aged; Anticholesteremic Agents; Apolipoproteins B; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry, Physical; Cholesterol, LDL; Colestipol; Combined Modality Therapy; Coronary Artery Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Lipase; Lipids; Lipolysis; Lipoproteins; Liver; Lovastatin; Male; Middle Aged; Niacin

1999
Serial quantitative coronary angiography and coronary events.
    American heart journal, 2000, Volume: 139, Issue:6

    Topics: Adult; Cholesterol, LDL; Colestipol; Collateral Circulation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Death, Sudden, Cardiac; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Niacin; Prognosis; Proportional Hazards Models

2000
Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography.
    Atherosclerosis, 2000, Volume: 150, Issue:2

    Topics: Adult; Carotid Artery, Common; Carotid Stenosis; Colestipol; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Observer Variation; Prognosis; Reproducibility of Results; Tunica Intima; Ultrasonography; Video Recording

2000
Comparison of computer- and human-derived coronary angiographic end-point measures for controlled therapy trials.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1992, Volume: 12, Issue:3

    Topics: Adult; Colestipol; Combined Modality Therapy; Computers; Coronary Angiography; Coronary Artery Disease; Humans; Male; Middle Aged; Niacin

1992
Effect of lovastatin or niacin combined with colestipol and regression of coronary atherosclerosis.
    European heart journal, 1992, Volume: 13 Suppl B

    Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Humans; Lovastatin; Male; Middle Aged; Niacin

1992
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.
    JAMA, 1990, Dec-19, Volume: 264, Issue:23

    Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Radiographic Image Interpretation, Computer-Assisted; Triglycerides

1990
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.
    JAMA, 1990, Dec-19, Volume: 264, Issue:23

    Topics: Adult; Apolipoproteins; Cholesterol; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Niacin; Radiography

1990
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
    Circulation, 1990, Volume: 81, Issue:2

    Topics: Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Niacin; Randomized Controlled Trials as Topic; Recurrence

1990
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
    Arquivos brasileiros de cardiologia, 1988, Volume: 51, Issue:1

    Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol

1988
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.
    JAMA, 1987, Jun-19, Volume: 257, Issue:23

    Topics: Adult; Clinical Trials as Topic; Colestipol; Coronary Artery Bypass; Coronary Artery Disease; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Lipids; Male; Middle Aged; Niacin; Polyamines; Radiography; Random Allocation

1987

Other Studies

3 other study(ies) available for colestipol and Arteriosclerosis, Coronary

ArticleYear
Use of neural networks in predicting the risk of coronary artery disease.
    Computers and biomedical research, an international journal, 1995, Volume: 28, Issue:1

    Topics: Adult; Cholesterol; Colestipol; Coronary Artery Disease; Coronary Disease; Diet, Fat-Restricted; Follow-Up Studies; Forecasting; Humans; Lipids; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Neural Networks, Computer; Niacin; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Risk Factors

1995
Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures. A comparison of different measures of treatment effect.
    Circulation, 1992, Volume: 86, Issue:6

    Topics: Adult; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Drug Therapy, Combination; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Niacin; Randomized Controlled Trials as Topic; Treatment Outcome

1992
Colestipol-niacin therapy and coronary atherosclerosis.
    JAMA, 1987, Nov-20, Volume: 258, Issue:19

    Topics: Adult; Colestipol; Coronary Artery Disease; Humans; Male; Middle Aged; Niacin; Polyamines; Research Design

1987